{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:28:05Z","timestamp":1790638085344,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bioorg.2020.103774","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T13:58:52Z","timestamp":1584626332000},"page":"103774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation"],"prefix":"10.1016","volume":"99","author":[{"given":"Pradeep S.","family":"Jadhavar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitij I.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas M.","family":"Dhameliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirjhar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maulikkumar D.","family":"Vaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagolu Siva","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmarajan","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asit K.","family":"Chakraborti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103774_b0005","unstructured":"World Health Organization (WHO), Global Tuberculosis Report, 2018. https:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"10.1016\/j.bioorg.2020.103774_b0010","unstructured":"Nobel Foundation. The Nobel Prize in Physiology or Medicine 1905, http:\/\/www.nobelprize.org\/nobel_prizes\/medicine\/laureates\/1905\/%253E."},{"key":"10.1016\/j.bioorg.2020.103774_b0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1473-3099(19)30168-9","article-title":"Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis","volume":"19","author":"Mohr","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.103774_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/crj.12044","article-title":"Risk factors for extensively drug-resistant tuberculosis: a review","volume":"8","author":"de Lima","year":"2014","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.bioorg.2020.103774_b0025","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.2174\/0929867323666151106125759","article-title":"Oxazolidinones as anti-tubercular agents: discovery, development and future perspectives","volume":"22","author":"Jadhavar","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0030","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","article-title":"Tuberculosis","volume":"387","author":"Dheda","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2020.103774_b0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jgg.2016.10.002","article-title":"Drug resistance mechanisms and novel drug targets for tuberculosis therapy","volume":"44","author":"Islam","year":"2017","journal-title":"J. Gene. Genom."},{"key":"10.1016\/j.bioorg.2020.103774_b0040","article-title":"Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-mycobacterium tuberculosis strains","volume":"9","author":"Hameed","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2020.103774_b0045","doi-asserted-by":"crossref","unstructured":"T.M Walker, M. Merker, A.M Knoblauch, P. Helbling, O.D. Schoch, M.J van der Werf, K. Kranzer, L. Fiebig, S. Kr\u00f6ger, W. Haas, H. Hoffmann, A. Indra, A. Egli, D.M Cirillo, J. Robert, T.R. Rogers, R. Groenheit, A.T. Mengshoel, V. Mathys, M. Haanper\u00e4, D. van Soolingen, S. Niemann, E.C B\u00f6ttger, P.M. Keller, and the MDR-TB Cluster Consortium, A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study, Lancet Infect Dis. 18 (2018) 431\u2013440.","DOI":"10.1016\/S1473-3099(18)30004-5"},{"key":"10.1016\/j.bioorg.2020.103774_b0050","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1039\/C4MD00224E","article-title":"N-arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: design, new methods of synthesis and biological evaluation","volume":"5","author":"Shah","year":"2014","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bioorg.2020.103774_b0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmech.2016.03.060","article-title":"Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: design, synthesis, biological evaluation and 3D-QSAR studies","volume":"116","author":"Pancholia","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejmech.2018.05.049","article-title":"Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: design, synthesis, biological evaluation, and structure-activity relationship","volume":"155","author":"Dhameliya","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0065","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.bmcl.2016.04.012","article-title":"Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents","volume":"26","author":"Jadhavar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103774_b0070","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1016\/j.bmcl.2016.10.082","article-title":"Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads","volume":"26","author":"Tanwar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103774_b0075","doi-asserted-by":"crossref","first-page":"9756","DOI":"10.1021\/jm401468w","article-title":"SAR Studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents","volume":"56","author":"Awasthi","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0080","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1021\/jm1012006","article-title":"Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents","volume":"54","author":"Kumar","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.tube.2014.03.007","article-title":"In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against mycobacterium tuberculosis","volume":"94","author":"Knudson","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bioorg.2020.103774_b0090","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/jac\/dkv226","article-title":"Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model","volume":"17","author":"Knudson","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2020.103774_b0095","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1021\/acs.jmedchem.5b00546","article-title":"Identification of phenoxyalkylbenzimidazoles with anti-tubercular activity","volume":"58","author":"Chandrasekera","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.pharep.2016.08.002","article-title":"Benzimidazole-core as an antimycobacterial agent","volume":"68","author":"Keri","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2020.103774_b0105","first-page":"1","article-title":"Undeniable pharmacological potentials of quinazoline motifs in therapeutic medicine","volume":"7","author":"Olayinka","year":"2017","journal-title":"Am. J. Drug Disc. Dev."},{"key":"10.1016\/j.bioorg.2020.103774_b0110","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/00397911.2018.1431282","article-title":"Current perspectives on quinazolines with potent biological activities: a review","volume":"48","author":"Gupta","year":"2018","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2020.103774_b0115","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1021\/acsmedchemlett.7b00239","article-title":"Mtb PKNA\/PKNB dual inhibition provides selectivity advantages for inhibitor design to minimize host kinase interactions","volume":"8","author":"Wang","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103774_b0120","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ejmech.2017.07.060","article-title":"The antitrypanosomal and antitubercular activity of some nitro(triazole\/imidazole)-based aromatic amines","volume":"138","author":"Papadopoulou","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bioorg.2018.09.023","article-title":"\u03b1-Sulfonamidophosphonates as new anti-mycobacterial chemotypes: design, development of synthetic methodology, and biological evaluation","volume":"82","author":"Bhagat","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1039\/C3MD00388D","article-title":"\u03b1-Aminophosphonates as novel anti-leishmanial chemotypes: synthesis, biological evaluation, and CoMFA studies","volume":"5","author":"Bhagat","year":"2014","journal-title":"MedChemComm."},{"key":"10.1016\/j.bioorg.2020.103774_b0135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/ml400500e","article-title":"2-(2-Arylphenyl)benzoxazole as a novel anti-inflammatory scaffold: synthesis and biological evaluation","volume":"5","author":"Seth","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103774_b0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.drudis.2011.10.024","article-title":"Classification of scaffold hopping approaches","volume":"17","author":"Sun","year":"2012","journal-title":"Drug Disc. Today"},{"key":"10.1016\/j.bioorg.2020.103774_b0145","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF00758335","article-title":"Synthesis and anticonvulsant activity of benzimidazo[1,2-c]quinazolines","volume":"20","author":"Vostrova","year":"1986","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.bioorg.2020.103774_b0150","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jhet.5570340316","article-title":"Benzimidazo[1,2-c]quinazoline dimers as potential antitumor agents","volume":"34","author":"Bra\u00f1a","year":"1997","journal-title":"J. Heterocycl Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0155","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0960-894X(00)00427-3","article-title":"Expeditious synthesis and cytotoxic activity of new cyanoindolo[3,2-c]quinolines and benzimidazo[1,2-c]quinazolines","volume":"10","author":"Lamazzi","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103774_b0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-827X(01)01079-5","article-title":"Synthesis, in vitro antiproliferative activity and DNA-interaction of benzimidazoquinazoline derivatives as potential anti-tumor agents","volume":"56","author":"Via","year":"2001","journal-title":"Il Farmaco"},{"key":"10.1016\/j.bioorg.2020.103774_b0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4067\/S0716-97602008000100006","article-title":"Biological evaluation of novel 6-Arylbenzimidazo [1,2-c]quinazoline derivatives as inhibitors of LPS-induced TNF-alpha secretion","volume":"41","author":"Galarce","year":"2008","journal-title":"Biol. Res."},{"key":"10.1016\/j.bioorg.2020.103774_b0170","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4067\/S0717-97072006000200018","article-title":"Synthesis, characterization and in vitro antifungal evaluation of novel benzimidazol[1,2-c]quinazolines","volume":"51","author":"Insuasty","year":"2006","journal-title":"J. Chil. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103774_b0175","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1016\/j.ejmech.2009.03.022","article-title":"Mono and bis-6-arylbenzimidazo [1,2-c]quinazolines: a new class of antimicrobial agents","volume":"44","author":"Rohini","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S0103-50532010000100009","article-title":"Synthesis and antimicrobial activities of a new class of 6-arylbenzimidazo[1,2-c]quinazolines","volume":"21","author":"Rohini","year":"2010","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103774_b0185","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/ja01559a053","article-title":"The use of polyphosphoric acid in the synthesis of 2-aryl- and 2-alkyl-substituted benzimidazoles, benzoxazoles and benzothiazolesl","volume":"79","author":"Hein","year":"1957","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103774_b0190","first-page":"941","article-title":"Synthesis, characterization and antimicrobial activity of some 3-(2-(1H-benzo[d]imidazole-2-yl)phenyl)-2-arylthiazolidin-4-ones","volume":"50B","author":"Desai","year":"2011","journal-title":"Ind. J. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0195","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3109\/14756366.2011.598867","article-title":"Synthesis, biological screening and molecular modeling studies of novel 3-chloro-4-substituted-1-(2-(1H-benzimidazol-2-yl)phenyl))-azetidin-2-ones","volume":"27","author":"Chhajed","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0200","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1021\/jo070433l","article-title":"Excited-state intramolecular proton transfer in 2-(2'-arylsulfonamidophenyl)benzimidazole derivatives: the effect of donor and acceptor substituents","volume":"72","author":"Henary","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0205","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1080\/00397910701489453","article-title":"Efficient method for the synthesis of benzimidazoquinazoline derivatives with three-point diversity","volume":"37","author":"Saha","year":"2007","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2020.103774_b0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3998\/ark.5550190.0010.c11","article-title":"Microwave-assisted synthesis and regioisomeric structural elucidation of novel benzimidazo[1,2d][1,4]benzodiazepinone derivatives","volume":"xii","author":"Mahana","year":"2009","journal-title":"Arkivoc"},{"key":"10.1016\/j.bioorg.2020.103774_b0215","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1039\/c4ob00206g","article-title":"A selenium-contained aggregation-induced \u201cturnon\u201d fluorescent probe for hydrogen peroxide","volume":"12","author":"Liao","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0220","doi-asserted-by":"crossref","first-page":"11687","DOI":"10.1039\/C5OB01777G","article-title":"Efficient one-pot two catalyst system in the construction of 2-substituted benzimidazoles: synthesis of benzimidazo[1,2-c]quinazolines","volume":"13","author":"Cimarelli","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/hc-2017-0046","article-title":"An efficient green synthesis of 5H-spiro[benzo[4,5]imidazo[1,2-c]quinazoline-6,3\u2032-indolin]-2\u2032-ones catalyzed by iodine in ionic liquids","volume":"23","author":"Zhang","year":"2017","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.bioorg.2020.103774_b0230","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1039\/C8NJ05150J","article-title":"Design, synthesis, antifungal activity and 3D-QSAR study of novel pyrazole carboxamide and niacinamide derivatives containing benzimidazole moiety","volume":"43","author":"Si","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0235","first-page":"1401","volume":"9","author":"Kumar","year":"2005","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2020.103774_b0240","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1055\/s-2004-820012","volume":"5","author":"Chakraborti","year":"2004","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2020.103774_b0245","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1055\/s-2004-829089","volume":"9","author":"Chakraborti","year":"2004","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2020.103774_b0250","first-page":"2521","volume":"15","author":"Rudrawar","year":"2005","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2020.103774_b0255","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1071\/CH08193","volume":"61","author":"Kumar","year":"2008","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/acs.joc.6b02423","article-title":"Nickel-catalyzed aerobic oxidative isocyanide insertion: access to benzimidazoquinazoline derivatives via sequential double annulation cascade (SDAC) strategy","volume":"82","author":"Shinde","year":"2016","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0265","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/anie.196708782","article-title":"Condensed imidazoles from \u03b1-diamines and isatoic anhydrides","volume":"6","author":"Taylor","year":"1967","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2020.103774_b0270","doi-asserted-by":"crossref","first-page":"10077","DOI":"10.1021\/acs.joc.7b01548","article-title":"Rationalisation of benzazole-2-carboxylate vs benzazine-3-one\/benzazine-2,3-dione selectivity switch during cyclocondensation of 2-amino thiophenols\/phenols\/anilines with 1,2-biselectrophiles in aqueous medium","volume":"82","author":"Dhameliya","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0275","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1021\/jo990780y","article-title":"Selective deprotection of aryl acetates, benzoates, pivalates and tosylates under non-hydrolytic and virtually neutral condition","volume":"64","author":"Chakraborti","year":"1999","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0280","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1021\/jo0163039","article-title":"The influence of hydrogen bonding in activation of nucleophile: PhSH \u2013 (Catalytic) KF in NMP as an efficient protocol for selective cleavage of alkyl\/aryl esters and aryl alkyl ethers under nonhydrolytic and neutral conditions","volume":"67","author":"Chakraborti","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0285","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1021\/jo0256540","article-title":"Demand-based thiolate anion generation under virtually neutral conditions: the influence of steric and electronic factors on chemo- and regio-selective cleavage of aryl alkyl ethers","volume":"67","author":"Chakraborti","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/jo01135a017","article-title":"An antimalarial alakaloid from hydrangea. XVII. Some 5-substituted derivatives","volume":"17","author":"Baker","year":"1952","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0295","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/anie.198002221","article-title":"Oxidation of isatins to isatoic anhydrides and 2,3-dioxo-1,4-benzoxazines","volume":"4","author":"Reissenweber","year":"1980","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2020.103774_b0300","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1080\/00397919908086422","article-title":"A facile synthesis of 6-substituted benzimidazo[1,2-c]quinazolines under microwave irradiation","volume":"29","author":"Khajavi","year":"1999","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2020.103774_b0305","unstructured":"P. Wayne, National Committee for Clinical Laboratory Standards. Anti-mycobacterial susceptibility testing for Mycobacterium tuberculosis, tentative standard M24-T, 1995."},{"key":"10.1016\/j.bioorg.2020.103774_b0310","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0315","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Dis."},{"key":"10.1016\/j.bioorg.2020.103774_b0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2020.103774_b0325","unstructured":"Molinspiration Online Software, http:\/\/www.molinspiration.com\/services\/ (accessed August 2, 2018)."},{"key":"10.1016\/j.bioorg.2020.103774_b0330","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1021\/acsomega.8b00805","article-title":"Synthesis of N-fused benzimidazole-4,7-diones via sequential copper-catalyzed C-N coupling\/cyclization and oxidation","volume":"3","author":"Dao","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2020.103774_b0335","first-page":"1591","article-title":"Microwave assisted synthesis of fused benzimidazoles","volume":"22","author":"Davoodnia","year":"2010","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0340","doi-asserted-by":"crossref","first-page":"15636","DOI":"10.1039\/c3ra41644e","article-title":"General and efficient copper-catalyzed aerobic oxidative synthesis of N-fused heterocycles using amino acids as the nitrogen source","volume":"3","author":"Liu","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2020.103774_b0345","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ejoc.201601329","article-title":"Synthesis of quinazolinones, imidazo[1,2-c] quinazolines and imidazo[4,5-c]quinolines through tandem reductive amination of aryl halides and oxidative amination of C(sp3)-H bond","volume":"2017","author":"Kumar","year":"2017","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103774_b0350","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1039\/C1CC10383K","article-title":"Copper-catalyzed cascade synthesis of benzimidazoquinazoline derivatives under mild condition","volume":"47","author":"Xu","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2020.103774_b0355","first-page":"41","article-title":"New Bronchodilators-2: synthesis of 6-alkylbenzimidazo[1,2-c]quinazolines","volume":"62","author":"Bahekar","year":"2000","journal-title":"Ind. J. Pharm. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820303424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820303424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:57:52Z","timestamp":1758614272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820303424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":71,"alternative-id":["S0045206820303424"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103774","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103774"}}